FDA Device Intelligence
HomeBIO-RAD LABORATORIES, INC. › BioPlex 2200

BioPlex 2200

BIO-RAD LABORATORIES, INC. · Model SW 4_2 · UDI-DI 00847865002189

LJYLJBLFYOPL
8
510(k) clearances
7
Adverse events
7
Recalls
21
Facilities

Description

U.S. IFU, Manual & CDs, BioPlex 2200, MMRV IgG IFU, SW4_v2

Recalls

DateFirmReason
2021-09-22bioMerieux, Inc.bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed result
2018-01-05Diamedix CorporationContains a gel-like contaminant that may affect product performance.
2014-10-20Diamedix CorporationA gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.
2013-01-23Bion Enterprises LtdAffected products have a labeled expiration date of one year too long.
2012-03-08Zeus Scientific, Inc.Select lots of AtheNA Multi-Lyte MMV Test System have lost reactivity and may produce false positive results in seronegative patients who have not been previously affected with or
2008-08-27Calbiotech IncThe recall has been initiated due to the "For Export Only" labeling found on some Calbiotech, Inc. ELISA kits. Although there is no potential health hazard related to this recall,
2005-08-08Diasorin Inc.Potential for false negative results. A software anomaly may occur when performing the ETI-Mumps IgG assay on the ETI-Max 3000 automated platform. The error occurs when running a

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.